Latest contributions
TAVI and the left ventricular myocardium
23 May 2025 – From EuroPCR 2025
Understand the intricate relationship between TAVI and left ventricular myocardium through discussions on cardiac damage stages, functional remodeling, and pharmacological interventions post-TAVR. This session also reviews prophylactic ECMO support in high-risk patients, offering a comprehensive perspective on optimizing TAVI outcomes.
Innovation to address unmet clinical needs in transcatheter valve therapies
22 May 2025 – From EuroPCR 2025
Discover innovations addressing unmet clinical needs in transcatheter valve therapies. This session shares case-based experiences including young aortic stenosis patients, mitral regurgitation with annular calcification, and severe tricuspid regurgitation with right ventricular dysfunction, alongside the latest advances in TAVI, TMVR, and tricuspid interventions.
Innovations in transcatheter aortic valve devices and techniques
22 May 2025 – From EuroPCR 2025
Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...
TAVI in patients with a small annulus
20 May 2025 – From EuroPCR 2025
Address the unique challenges of transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli. This session discusses comparative outcomes of balloon-expandable versus self-expandable valves, size prediction methodologies, and management of paravalvular regurgitation in low-flow, low-gradient aortic stenosis cases.
Valve haemodynamics and long-term durability
26 Nov 2024 – From PCR London Valves 2024
Curious about valve durability and haemodynamics? This session is for you!
You'll discover why echocardiographic and invasive measurements of valve gradients differ, gain insights into the performance of surgical versus transcatheter valves, explore the latest knowledge on structural valve degeneration and learn how interventional techniques may influence...
TAVI in women - Recent trials and current understanding
25 Nov 2024 – From PCR London Valves 2024
Looking to learn more about gender-based differences in the presentation and management of aortic stenosis? Dont' miss this video on the specifics of TAVI in women!
You'll discover how aortic stenosis presents uniquely in female patients, review the latest data on TAVI outcomes in women, and gain...
New frontiers in TAVI: have we reached them?
25 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in TAVI as we look into the results of the EARLY TAVR and RHEIA trials. Explore how these groundbreaking findings may influence clinical practice guidelines and shape the future of TAVI, as well as the remaining unmet clinical needs in TAVI.
Valve-in-valve: utility of splitting devices
15 May 2024 – From EuroPCR 2024
This session focuses on the use of specialized splitting devices for transcatheter aortic valve-in-valve procedures. It features a case series demonstrating the application of a dedicated splitting device in failed TAVI valves, as well as the use of the BASILICA technique for transcatheter aortic valve replacement....
How does the female heart respond to severe aortic stenosis and aortic intervention?
15 May 2024 – From EuroPCR 2024
In this session, gain insights into the gender-specific differences among patients with aortic stenosis (AS) and their implications for treatment strategies. Explore the significance of hemodynamics and durability from a patient's perspective, shedding light on the importance of personalized care. Engage in discussions about the optimal...
Best contemporary clinical practice for TAVI
21 Nov 2023 – From PCR London Valves 2023
Watch this session if you wish to explore emerging trends for transcatheter aortic valve implantation in younger patients, the specific considerations for TAVI in individuals with an extended life expectancy, and examine how valve design and implantation techniques can impact long-term outcomes.
TAVI - Durability and long-term outcomes
20 Nov 2023 – From PCR London Valves 2023
Consult this session to learn more about TAVI durability and long-term outcomes through a selection of abstracts: delve into a comprehensive five-year durability analysis of an intra-annular self-expandable transcatheter aortic bioprosthesis, navigate through the complexities of long-term outcomes associated with prosthesis-patient mismatch following valve-in-valve TAVI, explore...
Structural valve deterioration of a small aortic bioprosthesis. How should I treat?
16 Nov 2022
What would be your treatment strategy in this challenging case of a 78-year-old male patient with a failed surgical bioprosthetic valve implanted 17 years ago and complex coronary artery disease with chronic total occlusion of the right coronary artery?
Author
Author
Author
TAVI durability: important considerations for patient lifetime management
18 May 2022 – From EuroPCR 2022
PCR's Got Talent - Round 1 - Session 2
17 May 2022 – From EuroPCR 2022
Consult this session to discover a selection of cases presented during the round 1 of PCR's Got Talent at EuroPCR 2022: tricuspid regurgitation and right ventricular-pulmonary artery coupling, TAVI vs. medical therapy in patients with borderline severe classical LFLG AS, the LIRA sizing method of TAVR...
Patient risk factors and outcome in contemporary TAVI
17 May 2022 – From EuroPCR 2022
Watch these videos to learn more about the patient's risk factors and outcome after TAVI in various situations: with atrial fibrillation and history of PCI, with Diabetes Mellitus, with aortic stenosis based on cardiac damage, and more!
Case-based learning for the Heart Valve team: TAVI failure - What are the options?
19 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the detection and management of structural valve deterioration and bioprosthetic valve failure, and discover the key role of imaging in patient assessment, with a selection of challenging clinical cases: a TAVI patient with structural valve deterioration, another one with infective endocarditis, and more!
Case-based learning for the Heart Valve Team: bioprosthetic valve thrombosis
18 Nov 2019 – From PCR London Valves 2019
Consult this session on bioprosthetic valve thrombosis to learn more about its detection and management, with a focus on the key role of imaging in the follow-up of patients, and discover how to identify patients at high risk of thrombosis or bleeding and their optimal management.
Late-Breaking Trials at PCR London Valves 2019 - Session 2
18 Nov 2019 – From PCR London Valves 2019
View this session from PCR London Valves 2019 presenting late-breaking trials on incidence, predictors and outcome of structural valve deterioration in transcatheter vs. SAVR, and percutaneous edge-to-edge repair for tricuspid regurgitation.
TAVI: stroke, cerebral protection and alternative vascular access
18 Nov 2019 – From PCR London Valves 2019
Consult this session to discover the results of various TAVI trials and studies, and learn more about stroke, cerebral embolic protection and alternative vascular access.
